Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bodén

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Nordic Journal of Psychiatry|March 4, 2024
The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depressionMartin Cernvall, Johan Bengtsson, Robert Bodén
Journal of Psychopharmacology (Oxford, England)|December 7, 2021
Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulationAndreas Frick, Jonas Persson, Robert Bodén
Journal of Clinical Psychopharmacology|May 10, 2016
Postinjection Delirium Syndrome Associated With Olanzapine Long-Acting InjectableCecilia Bengtsson, Björn Mikael Nilsson, Robert Bodén
Neuropsychiatric Disease and Treatment|July 29, 2016
Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acidDaniel Neider, Leif H Lindström, Robert Bodén
BMC Neurology|August 22, 2020
Pain trajectories of dorsomedial prefrontal intermittent theta burst stimulation versus sham treatment in depressionErika Malm, Wiebke Struckmann, Jonas Persson, et al.
Translational Psychiatry|June 14, 2022
Application of positron emission tomography in psychiatry-methodological developments and future directionsSimon Cervenka, Andreas Frick, Robert Bodén, et al.
Schizophrenia Research|October 23, 2009
Biochemical risk factors for development of obesity in first-episode schizophreniaRobert Bodén, Arvo Haenni, Leif Lindström, et al.
Nordic Journal of Psychiatry|September 21, 2013
Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophreniaRobert Bodén, Tore Abrahamsson, Gunnar Holm, et al.
Lakartidningen|April 16, 2020
Johan Bengtsson, Robert Bodén, Elin Törnblom, et al.
Upsala Journal of Medical Sciences|April 13, 2023
No effects on heart rate variability in depression after treatment with dorsomedial prefrontal intermittent theta burst stimulationJohan Bengtsson, Erik Olsson, Jonas Persson, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Nordic Journal of Psychiatry|March 4, 2024
The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depressionMartin Cernvall, Johan Bengtsson, Robert Bodén
Journal of Psychopharmacology (Oxford, England)|December 7, 2021
Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulationAndreas Frick, Jonas Persson, Robert Bodén
Journal of Clinical Psychopharmacology|May 10, 2016
Postinjection Delirium Syndrome Associated With Olanzapine Long-Acting InjectableCecilia Bengtsson, Björn Mikael Nilsson, Robert Bodén
Neuropsychiatric Disease and Treatment|July 29, 2016
Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acidDaniel Neider, Leif H Lindström, Robert Bodén
BMC Neurology|August 22, 2020
Pain trajectories of dorsomedial prefrontal intermittent theta burst stimulation versus sham treatment in depressionErika Malm, Wiebke Struckmann, Jonas Persson, et al.
Translational Psychiatry|June 14, 2022
Application of positron emission tomography in psychiatry-methodological developments and future directionsSimon Cervenka, Andreas Frick, Robert Bodén, et al.
Schizophrenia Research|October 23, 2009
Biochemical risk factors for development of obesity in first-episode schizophreniaRobert Bodén, Arvo Haenni, Leif Lindström, et al.
Nordic Journal of Psychiatry|September 21, 2013
Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophreniaRobert Bodén, Tore Abrahamsson, Gunnar Holm, et al.
Lakartidningen|April 16, 2020
Johan Bengtsson, Robert Bodén, Elin Törnblom, et al.
Upsala Journal of Medical Sciences|April 13, 2023
No effects on heart rate variability in depression after treatment with dorsomedial prefrontal intermittent theta burst stimulationJohan Bengtsson, Erik Olsson, Jonas Persson, et al.
Pageof 8